HIGHLIGHTS
- who: Ermes Carulli and collaborators from the ctoral Programme in Translational Medicine, Universitu00e0 di Milano, Milan, Italy have published the Article: Human Hematopoietic Stem/Progenitor Cells in Type One Diabetes Mellitus Treatment: Is There an Ideal Candidate?, in the Journal: Cells 2023, 12, 1054. of /2023/
- what: The last, intriguing alternative was cell therapy; indeed, in this manuscript, the authors will review the attempts made so far in treating T1DM with hematopoietic stem/progenitor cell (HSPC) therapy. This approach had the potential to prove a more effective, less risky and expensive, and lifelong immunosuppression-free . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.